BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36563680)

  • 1. Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer.
    Teng H; Wang Y; Sui X; Fan J; Li S; Lei X; Shi C; Sun W; Song M; Wang H; Dong D; Geng J; Zhang Y; Zhu X; Cai Y; Li Y; Li B; Min Q; Wang W; Zhan Q
    Cancer Cell; 2023 Jan; 41(1):124-138.e6. PubMed ID: 36563680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study.
    Yi Y; Shen L; Shi W; Xia F; Zhang H; Wang Y; Zhang J; Wang Y; Sun X; Zhang Z; Zou W; Yang W; Zhang L; Zhu J; Goel A; Ma Y; Zhang Z
    Clin Cancer Res; 2021 Mar; 27(5):1329-1340. PubMed ID: 33298472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective, longitudinal analysis of the gut microbiome in patients with locally advanced rectal cancer predicts response to neoadjuvant concurrent chemoradiotherapy.
    Sun Y; Zhang X; Jin C; Yue K; Sheng D; Zhang T; Dou X; Liu J; Jing H; Zhang L; Yue J
    J Transl Med; 2023 Mar; 21(1):221. PubMed ID: 36967379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 5. The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients-A Pilot Study.
    Shi W; Shen L; Zou W; Wang J; Yang J; Wang Y; Liu B; Xie L; Zhu J; Zhang Z
    Front Cell Infect Microbiol; 2020; 10():562463. PubMed ID: 33363048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer.
    Serna G; Ruiz-Pace F; Hernando J; Alonso L; Fasani R; Landolfi S; Comas R; Jimenez J; Elez E; Bullman S; Tabernero J; Capdevila J; Dienstmann R; Nuciforo P
    Ann Oncol; 2020 Oct; 31(10):1366-1375. PubMed ID: 32569727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ceRNA Networks: The Backbone Role in Neoadjuvant Chemoradiotherapy Resistance/Sensitivity of Locally Advanced Rectal Cancer.
    He L; Chang H; Qi Y; Zhang B; Shao Q
    Technol Cancer Res Treat; 2021; 20():15330338211062313. PubMed ID: 34908512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of stromal cell-derived factor 1α expression is associated with the resistance to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: angiogenic markers of neoadjuvant chemoradiation.
    Kim HJ; Bae SB; Jeong D; Kim ES; Kim CN; Park DG; Ahn TS; Cho SW; Shin EJ; Lee MS; Baek MJ
    Oncol Rep; 2014 Dec; 32(6):2493-500. PubMed ID: 25241658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAD18 may function as a predictor of response to preoperative concurrent chemoradiotherapy in patients with locally advanced rectal cancer through caspase-9-caspase-3-dependent apoptotic pathway.
    Yan X; Chen J; Meng Y; He C; Zou S; Li P; Chen M; Wu J; Ding WQ; Zhou J
    Cancer Med; 2019 Jun; 8(6):3094-3104. PubMed ID: 31033216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the tumor microenvironment and identification of spatially predictive biomarkers associated with beneficial neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Zhang S; Li N; Wang F; Liu H; Zhang Y; Xiao J; Qiu W; Zhang C; Fan X; Qiu M; Li M; Tang H; Fan S; Wang J; Luo H; Li X; Lin J; Huang Y; Liang L
    Pharmacol Res; 2023 Nov; 197():106974. PubMed ID: 37898442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbes promote chemoradiotherapy resistance via metabolic cross-feeding.
    Wong CC; Fong W; Yu J
    Cancer Cell; 2023 Jan; 41(1):12-14. PubMed ID: 36563683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of CD133 in rectal cancer tissues and its relationship with neoadjuvant chemoradiotherapy].
    Li D; Wu H; Feng R; Zhong D; Luo Y; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):690-4. PubMed ID: 27353106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic Mutations and Immune Alternation in Rectal Cancer Following Neoadjuvant Chemoradiotherapy.
    Ji D; Yi H; Zhang D; Zhan T; Li Z; Li M; Jia J; Qiao M; Xia J; Zhai Z; Song C; Gu J
    Cancer Immunol Res; 2018 Nov; 6(11):1401-1416. PubMed ID: 30282671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Huang MY; Huang CW; Wang JY
    Kaohsiung J Med Sci; 2020 Mar; 36(3):152-159. PubMed ID: 31814296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
    Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
    BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic variations in MLH3 and MSH2 genes are associated with the sensitivity and prognosis in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy].
    Yang J; Wang X; Zou SM; Li HM; Xiao Q; Feng YR; Huang Y; Feng T; Chen JN; Lin DX; Li YX; Jin J; Tan W
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):433-440. PubMed ID: 29936769
    [No Abstract]   [Full Text] [Related]  

  • 17. An integrated multiomics analysis of rectal cancer patients identified POU2F3 as a putative druggable target and entinostat as a cytotoxic enhancer of 5-fluorouracil.
    D'Angelo E; Pastrello C; Biccari A; Marangio A; Sensi F; Crotti S; Fassan M; Jurisica I; Pucciarelli S; Agostini M
    Int J Cancer; 2023 Jul; 153(2):437-449. PubMed ID: 36815540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of carcinoembryonic antigen combined with carbohydrate antigen 19-9 following neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Zheng Z; Wang X; Lu X; Huang Y; Chi P
    Colorectal Dis; 2021 Sep; 23(9):2320-2330. PubMed ID: 33900006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy.
    Dou X; Wang R; Meng X; Yan H; Jiang S; Zhu K; Xu X; Chen D; Song X; Mu D
    Cancer Biomark; 2015; 15(2):181-8. PubMed ID: 25519018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer.
    Zhang Y; Yan L; Wu Y; Xu M; Liu X; Guan G
    BMC Cancer; 2020 Sep; 20(1):854. PubMed ID: 32891131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.